Rhinitis medicamentosa.

M J, Black; K A, Remsen

Found an issue? Give us feedback

https://pubmed.ncbi....arrow_drop_down

https://pubmed.ncbi.nlm.nih.go...

Article . 1980

Data sources: Europe PubMed Central

Rhinitis medicamentosa.

descriptionPublicationkeyboard_double_arrow_right Article 28 Jul 1980 English Journal:Canadian Medical Association journal, volume 122 (issn: 0008-4409,

Copyright policy )

Authors: M J, Black; K A, Remsen;

pmid: 6154514

pmc: PMC1801634

Rhinitis medicamentosa.

- Summary
- Subjects
- Metrics

Abstract

Rhinitis medicamentosa, the syndrome of rebound nasal congestion secondary to prolonged topical intranasal use of vasoconstrictors, is reviewed. In this condition, the nasal airway is very obstructed; atrophic rhinitis is the most serious complication. Management consists of withdrawing the offending nasal spray and alleviating the nasal obstruction by means of any of several treatment modalities.

Keywords

Nasal Decongestants, Rhinitis, Vasomotor, Humans, Nose

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	28
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average